Health and Pharmaceutical

Although the health sector is examined under a single heading, it actually includes many independent sub-sectors in a wide range. Its two main branches are pharmacology, that is, the pharmaceutical and hospital sectors. Pharmacology tries to develop treatment methods for diseases for which there is no cure yet, or to improve existing treatments. The hospital sector, on the other hand, aims to maximize the services provided to patients. Other sub-sectors include biotechnology, medical device development and health insurance services.

Thanks to this diversity, the health sector attracts many investors from large to small. Large companies, some of which have been operating in the pharmaceutical industry for a hundred years, appeal to large investors who want a guaranteed return and do not want to take risks. On the other hand, stocks whose value changes day by day in the field of biotechnology, where new developments emerge almost every day, offer investment opportunities to smaller investors looking for adventure. It should be noted that these sub-sectors are subject to different regulations and their dynamics can vary greatly between countries.

The largest economic player in the field of health is, of course, the pharmaceutical sector. Painkillers, antipyretic drugs, commonly used antibiotics, whose names are known to everyone who have been in our lives for a long time, constitute a large part of the income of companies in the pharmaceutical industry.

The Health and Pharmaceuticals sector, where the demand is constantly increasing in parallel with the large population structure, stands out as a market that does not experience any sustainability problems due to the inelastic demand. The sector, supported by the increase in the average life expectancy, continues to grow with the concept of the social state, whose importance is increasing.

On the other hand, rapidly increasing technological developments; while helping the industry to go beyond its own borders, it also creates new areas of expansion. The industry is growing not only in the field of therapeutic drugs, but also with a high potential sub-branch classified as consumer products aimed at increasing the quality of life.

The approximate size of the global pharmaceutical industry by the end of 2019 is 1.3 trillion USD. The sector, which grew by 4% compared to 2018, is expected to grow by 4.5% on average in the 2020-2023 period, exceeding the level of 1.5 trillion USD.

The healthcare industry has responded very quickly to the shock it faced with the COVID-19 pandemic. While the industry has transferred a significant part of its business practices to virtual platforms and digital technologies in a very short time, it has realized reforms that could cost ten years in a few months. Turkey continues to play a leading role in the Health Sector both in its region and in the world. With the development of technological infrastructures in recent years, Turkey has become a center of attraction both in medical equipment, drugs, treatment methods and successful results.